Neonicotinoid Pesticide Linked To Brain Damage In Study, Spotlights a Mechanism Ignored by Regulators

By cocosomers // 2026-10-09

Mastodon

Parler

Gab

Copy

Researchers at the Istituto Superiore di Sanità in Rome published a study in the journal Neurotoxicology finding that the neonicotinoid insecticide acetamiprid alters the physiology of human microglial cells in vitro at concentrations corresponding to 90 percent of the European Food Safety Authority's safe blood level, according to the paper. The study, titled "Toxic effects of Acetamiprid on the human microglial cell line HMC3," was conducted at the National Center for Drug Research and Evaluation.

Study Findings on Human Microglial Cells

The researchers used a validated in vitro model of human microglial cells, which serve as the central nervous system's primary maintenance mechanism, scavenging for damaged cells, plaques and infectious agents, according to the study [1]. Microglia are essential to brain development, the ability of neuronal synapses to adapt to changing conditions, and defense against inflammation, the researchers stated. Acetamiprid alone significantly increased the microglia's phagocytic activity, the degree to which they engulfed foreign objects, the study found. The cells treated with both substances stayed alive but appeared unable to fully engage their inflammatory responses to the challenges. They also observed that over time, even though the cells' metabolic activity slowed and they showed other signs of stress, the apoptotic process did not result in significant programmed cell death. The study described accumulated cell stress prior to measurable effects on proliferation or survival. The research adds to a body of scientific literature on neonicotinoid neurotoxicity.

Regulatory History and Prior Assumptions

Imidacloprid, the first commercial neonicotinoid, was registered by the U.S. Environmental Protection Agency in 1994. In 1994, the EPA waived neurotoxicity testing for hens and mammals, stating that no evidence of neurotoxicity had been observed in acute or chronic exposure. The EPA's 2020 Proposed Interim Registration Review Decision for acetamiprid stated that no risks of concern were identified for dietary, residential, aggregate, bystander or occupational post-application exposures. The agency also stated it did not anticipate any further human health data needs for the acetamiprid registration review at that time. The EPA also assumed that neonics were unlikely to cross the blood-brain barrier, according to Beyond Pesticides. The organization also stated that a switch to organic, regenerative agriculture could change this trajectory quickly.

Exposure Data and Broader Research

Research published in Environmental Health Perspectives found the presence of nine various neonicotinoids and six neonic metabolites within human cerebrospinal fluid, an essential part of the central nervous system, according to Children's Health Defense [2]. Specific chemical biomarkers like pesticides found in cerebrospinal fluid are useful for diagnosing and evaluating numerous neurological diseases. A check of 196 young Chinese adults found imidacloprid in 85 percent of the samples, and a study of 305 children in South China found six neonics in 90 percent of them. Levels in the U.S. general population were lower, with the highest detection frequency of imidacloprid at 4.3 percent. Neonics are also used as seed treatments for major crops. A study published in Environmental Science and Technology found that neonicotinoids and their breakdown products can readily transfer from mother to fetus, according to Children's Health Defense [3].

Study Limitations and Next Steps

The findings are based on an in vitro cell model and have not been confirmed in whole-animal or human studies. The authors noted the dosage aligned with regulatory-relevant scenarios but called for further research. The EPA stated in its 2020 review that it did not anticipate further human health data needs for the acetamiprid registration review at that time. No timeline has been announced for EPA reconsideration of microglial or developmental neurotoxicity endpoints, according to federal records. The agency has previously maintained that acetamiprid is not likely to be carcinogenic in humans and that no risks of concern were identified for various exposure pathways. The organization described the Forum as an opportunity for scientists to speak on the pesticide threat to human health and ecosystems. The group also maintains a Gateway on Pesticide Hazards and Safe Pest Management providing details on all neonicotinoids. The broader scientific context continues to evolve. A review by researchers C. Costas-Ferreira and L.R.F. A separate study by J.B. Sass and colleagues, published in Frontiers in Toxicology in 2024, reported statistically significant shrinkage of brain tissue observed in high-dose offspring for five neonicotinoids: acetamiprid, clothianidin, imidacloprid, thiacloprid and thiamethoxam [4].

References

Common Pesticide Kills Brain Cells — Regulators Continue to Ignore.... https://childrenshealthdefense.org/defender/pesticide-kills-brain-cells-regulators-ignore-evidence/
How Neonicotinoid Insecticides Adversely Affe - ChildrensHealthDefense.org by ChildrensHealthDefense.org
Neonicotinoid Insecticides Added to Growing L - ChildrensHealthDefense.org by ChildrensHealthDefense.org
Neonicotinoid pesticides: evidence of developmental .... https://pubmed.ncbi.nlm.nih.gov/39415959/

Explainer Infographic